NCT01851369 2024-05-08
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
National Institutes of Health Clinical Center (CC)
Spanish Breast Cancer Research Group
China Medical University Hospital
Amsterdam UMC, location VUmc
Merck Sharp & Dohme LLC
Medtronic - MITG
Sanofi
Swiss Cancer Institute
Mahidol University